Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

Phase 1 Trial of Prophylactic Donor-Derived IL-2 Activated NK Cell Infusion after Allogeneic Hematopoietic Stem Cell Transplantation from a Matched Sibling Donor

Raynier Devillier, Boris Calmels, Pharm.D., Sophie Guia, Cyril Fauriat, Sabine Furst, Samia Harbi, Angela Granata, MD, Sophie Ugolini, Christian Chabannon, MD PhD, Daniel Olive, MD PhD, Eric Vivier, Didier Blaise, MD

Blood (2020) 136 (Supplement 1): 6–7.

https://doi.org/10.1182/blood-2020-140753

Published: 2020

Journal Articles

Anti-BTN3A 20.1 Agonist Monoclonal Antibody Enhances Autologous Vγ9Vδ2 T Cells Cytotoxicity Against Primary Acute Myeloid Blasts

Anne-Charlotte Le Floch, MBBS, MSc, Florence Orlanducci, Antoine Briantais, Aude Le Roy, Anne-Sophie Chretien, Norbert Vey, MD PhD, Daniel Olive, MD PhD

Blood (2019) 134 (Supplement_1): 5153.

https://doi.org/10.1182/blood-2019-125541

Published: 2019

Journal Articles

BTN2A, a New Immune-Checkpoint Targeting Vg9Vd2 T Cell Cytotoxicity

Carla E Cano, PhD, Christine Pasero, Aude De Gassart, René Hoet, Emmanuel Scotet, Erwan Mortier, Agnes Quemeneur, Chirine Rafia, Antoine Briantais, Anne-Charlotte Le Floch, MBBS,MSc, Daniel Olive, MD PhD

Blood (2019) 134 (Supplement_1): 1044.

https://doi.org/10.1182/blood-2019-128658

Published: 2019

Journal Articles

Randomized Phase 2 Trial of Lirilumab (anti-KIR monoclonal antibody, mAb) As Maintenance Treatment in Elderly Patients (pts) with Acute Myeloid Leukemia (AML): Results of the Effikir Trial

Blood (2017) 130 (Supplement 1): 889.

https://doi.org/10.1182/blood.V130.Suppl_1.889.889

Published: 2017

Journal Articles

Follicular Lymphoma B Cells Generate Functional Regulatory T Cells Via ICOS/ICOSL Pathway and Are Inhibited By Intratumoral Tregs

Daniel Olive, MD, PhD, Suong Khieu LE, PhD, marie-Laure Thibult, Francoise gondois-Rey, Samuel Granjeaud, PhD, Thierry Fest, Azzaoui Imene, Reda Bouabdallah, MD, Florence Broussais, Luc Xerri, Dominique Leroux, Christophe Caux, Christine Caux

Blood (2015) 126 (23): 5018.

https://doi.org/10.1182/blood.V126.23.5018.5018

Published: 2015

Journal Articles

Vgamma9Vdelta2 T Cells-Based Immunotherapy Targeting BTN3 Molecules in Acute Myeloid Leukemia

Daniel Olive, MD, PhD, Audrey Benyamine, MD, Aude Le Roy, Rémy Castellano, PhD, Julie Gertner-Dardenne, Norbert Vey, MDPhD

Blood (2014) 124 (21): 3726.

https://doi.org/10.1182/blood.V124.21.3726.3726

Published: 2014

Journal Articles

Influence of Btk Inhibitors on Antitumor Activity of Natural Killer Cells

Marta Siernicka, MSc, Kamil Bojarczuk, MSc, Malgorzata Bobrowicz, MSc, Michal Dwojak, DMD, Beata Pyrzynska, PhD, Daniel Olive, MD, PhD, Magdalena Winiarska, PhD

Blood (2014) 124 (21): 2742.

https://doi.org/10.1182/blood.V124.21.2742.2742

Published: 2014

Journal Articles

Diffuse Large B Cell Lymphoma (DLBCL) infiltrating T Cells Display an Activated and Exhausted Status and Are Inhibited By Ligands of Cosignaling Receptors Including PD-L1, PD-L2 and CD80 Expressed By Most DLBCL in Situ

Daniel Olive, MD, PhD, Kieu Suong Le, Mikael Roussel, MD PhD, Florence Broussais, MD, Imane Azzaoui, PhD, Delphine Rossille, Reda Bouabdallah, MD, Thierry Fest, MD PhD, Luc Xerri, Thierry Lamy, MD PhD, Céline Pangault, PharmD, PhD

Blood (2014) 124 (21): 1665.

https://doi.org/10.1182/blood.V124.21.1665.1665

Published: 2014

Journal Articles

CD8+ /ICOS+ /CXCR5+ Tumor Infiltrating T-CELLS (CD8 fc ) Sharing Functional Similarities With TFH CELLS ARE Present In Classical Hodgkin’S Lymphoma Tissues Displaying A Specific “MIXED NODULARITY” Pattern

Suong Le Thi, M.D., Florence Broussais, Reda Bouabdallah, MD, Françoise gondois-Rey, Luc Xerri, MD, PhD, Daniel Olive, MD, PhD

Blood (2013) 122 (21): 4233.

https://doi.org/10.1182/blood.V122.21.4233.4233

Published: 2013

Journal Articles

NK Cells Display Poor Anti Lymphoma and AML Function At Early Times Following Allogenic HLA-Identical SCT for Leukemia and Lymphomas.

Daniel Olive, MD, PhD, Caroline Pical, Jean El-Cheikh, MD PhD, Roberto Crocchiolo, MD, Sabine Furst, MD, Didier Blaise, MD, Cyril Fauriat

Blood (2012) 120 (21): 3045.

https://doi.org/10.1182/blood.V120.21.3045.3045

Published: 2012

Journal Articles

Early Events of Innate Immune Response to Influenza Virus in a Complex Cellular Environment Revisited with Multi-Parametric Flow Cytometry

Daniel Olive, MD, PhD, Françoise gondois-Rey, Suong Le Thi Kieu, Diana Herrera, Ivan Hirsch

Blood (2011) 118 (21): 4931.

https://doi.org/10.1182/blood.V118.21.4931.4931

Published: 2011

Journal Articles

Defective Triggering of NK Cells Results in Primary CLL Cells Resistance to Cytotoxicity,

Caroline Veuillen, PhD, Jerome Rey, MD, Rémy Castellano, PhD, Florence Orlanducci, Françoise Mallet, Sylvaine Just-Landi, Diane Coso, MD, Vadim Ivanov, MD, PhD, Xavier Carcopino, MD, Reda Bouabdallah, MD, Yves Collette, PhD, Cyril Fauriat, PhD, Daniel Olive, MD, PhD, Thérèse Aurran, MD

Blood (2011) 118 (21): 3876.

https://doi.org/10.1182/blood.V118.21.3876.3876

Published: 2011

Journal Articles

Anti-Leukemic Effect of IMiDs® in AML Involves the Direct Cytotoxicity Effects in Addition to a Biased NK Activation,

Aude Le Roy, Norbert Vey, MD, Cyril Fauriat, Florence Orlanducci, Scott Bateman, Daniel Olive, MD, PhD

Blood (2011) 118 (21): 3224.

https://doi.org/10.1182/blood.V118.21.3224.3224

Published: 2011

Journal Articles

Natural Killer Cells Recovery After Consolidation Chemotherapy in Elderly Patients with Acute Myeloid Leukemia (AML)

Jerome Rey, MD, Nicolas Anfossi, PhD, Pascale Andre, PhD, Jean-Marie Boher, Florence Orlanducci, Violette Breso, Valentine Perri, Thomas Prebet, MD, PhD, Aude Charbonnier, MD, PhD, Eloïse Perrot, Francois Romagne, PhD, Norbert Vey, MD, Daniel Olive, MD, PhD

Blood (2011) 118 (21): 2189.

https://doi.org/10.1182/blood.V118.21.2189.2189

Published: 2011

Journal Articles

Analysis of NK Cells Receptors and NK Cells Ligands in Acute Myeloid Leukemia: Comparisons Between the Blood and the Bone Marrow.

Jerome Rey, Eloise Perrot, Caroline Veuillen, Thomas Prébet, MD, Anne Etienne, Aude Charbonnier, Evelyne D'Incan, Norbert Vey, Daniel Olive, MD, PhD

Blood (2009) 114 (22): 1643.

https://doi.org/10.1182/blood.V114.22.1643.1643

Published: 2009

Journal Articles

Long Lasting Alteration of Natural Killer Cells Post-Chemotherapy in Elderly Patients with Acute Myeloid Leukemia (AML).

Daniel Olive, MD, PhD, Nicolas Anfossi, Pascale Andre, PhD, Jerome Rey, Florence Orlanducci, Violette Breso, Valentine Peri, Thomas Prébet, MD, Aude Charbonnier, MD, PhD, Eloise Perrot, Francois Romagne, PhD, Norbert Vey

Blood (2009) 114 (22): 1653.

https://doi.org/10.1182/blood.V114.22.1653.1653

Published: 2009

Journal Articles

TCR and DNAM Dependent Lysis of Acute Monocytic Leukemia (AMoL) by Vg9Vd2 T Lymphocytes.

Julie Gertner-Dardenne, Eloise Perrot, Thomas Prebet, MD, Aude Charbonnier, Helene Sicard, PhD, Norbert Vey, Daniel Olive, MD, PhD

Blood (2009) 114 (22): 1041.

https://doi.org/10.1182/blood.V114.22.1041.1041

Published: 2009

Journal Articles

A Phase I Study of the Anti-Natural Killer Inhibitory Receptor (KIR) Monoclonal Antibody (1-7F9, IPH2101) in Elderly Patients with Acute Myeloid Leukemia (AML): Clinical and Immunological Effects of a Single Dose Followed by Repeated Dosing.

Norbert Vey, Jean-Henri Bourhis, MD, PhD, Herve Dombret, MD, PhD, Dominique Bordessoule, Thomas Prébet, MD, Aude Charbonnier, Stephane de Botton, Nicolas Boissel, MD, PhD, Christine d'Arnoux, MD, Francois Romagne, PhD, Pascale Andre, PhD, Jerome Tiollier, Patrick Squiban, Didier Blaise, Daniel Olive, MD, PhD

Blood (2009) 114 (22): 632.

https://doi.org/10.1182/blood.V114.22.632.632

Published: 2009

Journal Articles

Identification of Escape Mechanisms Involved in the Absence of Viral Control Despite Activation of Both Innate (natural killer and gammadelta T cells) and Virus-Specific T Cells in Children with CMV or EBV Disease Following Cord Blood Transplantation.

Laure Farnault, Gerard Michel, MD, Herve Chambost, Didier Blaise, MD, Sabine Furst, MD, Felix Montero, Ph.D., Emmanuel Gautherot, Ph.D., Julie gertner-Dardenne, Ivan Hirsch, Francoise gondois-Rey, Daniel Olive, MD, PhD

Blood (2009) 114 (22): 2659.

https://doi.org/10.1182/blood.V114.22.2659.2659

Published: 2009

Journal Articles

Anti-Acute Myeloid Leukemia Activity of Chaetocin, a Novel Epigenetic Drug Inhibitor Inducing Oxidative Stress.

Hassiba Chaib, BSc, Thomas Prebet, MD, Audrey Restouin, BSc, Remy Castellano, PhD, Sandrine Opi, PhD, Daniel Olive, MD, PhD, Jean Paul Borg, PD, PhD, Norbert Vey, MD, Yves Collette, PhD

Blood (2007) 110 (11): 889.

https://doi.org/10.1182/blood.V110.11.889.889

Published: 2007

NARROW

Phase 1 Trial of Prophylactic Donor-Derived IL-2 Activated NK Cell Infusion after Allogeneic Hematopoietic Stem Cell Transplantation from a Matched Sibling Donor

Anti-BTN3A 20.1 Agonist Monoclonal Antibody Enhances Autologous Vγ9Vδ2 T Cells Cytotoxicity Against Primary Acute Myeloid Blasts

BTN2A, a New Immune-Checkpoint Targeting Vg9Vd2 T Cell Cytotoxicity

Randomized Phase 2 Trial of Lirilumab (anti-KIR monoclonal antibody, mAb) As Maintenance Treatment in Elderly Patients (pts) with Acute Myeloid Leukemia (AML): Results of the Effikir Trial

Follicular Lymphoma B Cells Generate Functional Regulatory T Cells Via ICOS/ICOSL Pathway and Are Inhibited By Intratumoral Tregs

Vgamma9Vdelta2 T Cells-Based Immunotherapy Targeting BTN3 Molecules in Acute Myeloid Leukemia

Influence of Btk Inhibitors on Antitumor Activity of Natural Killer Cells

Diffuse Large B Cell Lymphoma (DLBCL) infiltrating T Cells Display an Activated and Exhausted Status and Are Inhibited By Ligands of Cosignaling Receptors Including PD-L1, PD-L2 and CD80 Expressed By Most DLBCL in Situ

CD8+ /ICOS+ /CXCR5+ Tumor Infiltrating T-CELLS (CD8 fc ) Sharing Functional Similarities With TFH CELLS ARE Present In Classical Hodgkin’S Lymphoma Tissues Displaying A Specific “MIXED NODULARITY” Pattern

NK Cells Display Poor Anti Lymphoma and AML Function At Early Times Following Allogenic HLA-Identical SCT for Leukemia and Lymphomas.

Early Events of Innate Immune Response to Influenza Virus in a Complex Cellular Environment Revisited with Multi-Parametric Flow Cytometry

Defective Triggering of NK Cells Results in Primary CLL Cells Resistance to Cytotoxicity,

Anti-Leukemic Effect of IMiDs® in AML Involves the Direct Cytotoxicity Effects in Addition to a Biased NK Activation,

Natural Killer Cells Recovery After Consolidation Chemotherapy in Elderly Patients with Acute Myeloid Leukemia (AML)

Analysis of NK Cells Receptors and NK Cells Ligands in Acute Myeloid Leukemia: Comparisons Between the Blood and the Bone Marrow.

Long Lasting Alteration of Natural Killer Cells Post-Chemotherapy in Elderly Patients with Acute Myeloid Leukemia (AML).

TCR and DNAM Dependent Lysis of Acute Monocytic Leukemia (AMoL) by Vg9Vd2 T Lymphocytes.

A Phase I Study of the Anti-Natural Killer Inhibitory Receptor (KIR) Monoclonal Antibody (1-7F9, IPH2101) in Elderly Patients with Acute Myeloid Leukemia (AML): Clinical and Immunological Effects of a Single Dose Followed by Repeated Dosing.

Identification of Escape Mechanisms Involved in the Absence of Viral Control Despite Activation of Both Innate (natural killer and gammadelta T cells) and Virus-Specific T Cells in Children with CMV or EBV Disease Following Cord Blood Transplantation.

Anti-Acute Myeloid Leukemia Activity of Chaetocin, a Novel Epigenetic Drug Inhibitor Inducing Oxidative Stress.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only